Back
Aldeyra Therapeutics Stock Price Chart
Buy
55
ALDX
Aldeyra Therapeutics
Last Price:
4.02
Seasonality Move:
25.2%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bearish and ALDX is experiencing slight buying pressure.
Aldeyra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.98 | Buy |
| 20-day SMA: | 4.02 | Buy |
| 50-day SMA: | 3.75 | Buy |
| 200-day SMA: | 4.13 | Sell |
| 8-day EMA: | 4.02 | Buy |
| 20-day EMA: | 4.01 | Buy |
| 50-day EMA: | 3.86 | Buy |
| 200-day EMA: | 4.36 | Sell |
Aldeyra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 51.69 | Buy |
| Chaikin Money Flow: | 109089 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.87 - 4.13) | Buy |
| Bollinger Bands (100): | (3.11 - 4.05) | Buy |
Aldeyra Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aldeyra Therapeutics Stock
Is Aldeyra Therapeutics Stock a Buy?
- Aldeyra Therapeutics share price is 4.03 while ALDX 8-day simple moving average is 3.98, which is a Buy signal.
- The stock price of ALDX is 4.03 while Aldeyra Therapeutics 20-day SMA is 4.02, which makes it a Buy.
- Aldeyra Therapeutics 50-day simple moving average is 3.75 while ALDX share price is 4.03, making it a Buy technically.
- ALDX stock price is 4.03 and Aldeyra Therapeutics 200-day simple moving average is 4.13, creating a Sell signal.
ALDX Technical Analysis vs Fundamental Analysis
Buy
55
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy or a Sell?
-
Aldeyra Therapeutics stock is rated a Buy
The current Aldeyra Therapeutics [ALDX] share price is $4.03. The Score for ALDX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Aldeyra Therapeutics Stock Info
Market Cap:
239.44M
Price in USD:
4.03
Share Volume:
245.45K
Aldeyra Therapeutics 52-Week Range
52-Week High:
11.97
52-Week Low:
1.42
Buy
55
Aldeyra Therapeutics (ALDX)
is a Buy
Aldeyra Therapeutics Share Price Forecast
-
What is the Aldeyra Therapeutics stock price today?
The Aldeyra Therapeutics stock price is 4.03 USD today. -
Will ALDX stock go up or go down?
Aldeyra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aldeyra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aldeyra Therapeutics is not overvalued.
Is Aldeyra Therapeutics Stock a Buy?
- Aldeyra Therapeutics share price is 4.03 while ALDX 8-day exponential moving average is 4.02, which is a Buy signal.
- The stock price of ALDX is 4.03 while Aldeyra Therapeutics 20-day EMA is 4.01, which makes it a Buy.
- Aldeyra Therapeutics 50-day exponential moving average is 3.86 while ALDX share price is 4.03, making it a Buy technically.
- ALDX stock price is 4.03 and Aldeyra Therapeutics 200-day simple moving average is 4.36, creating a Sell signal.
Fundamental Analysis of Aldeyra Therapeutics
Is Aldeyra Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Aldeyra Therapeutics
Should I short Aldeyra Therapeutics stock?
- ALDX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Aldeyra Therapeutics is a Buy
- Aldeyra Therapeutics Relative Strength Index (RSI) is 51.69, which suggest Aldeyra Therapeutics is overbought
- The Bollinger Bands (25) for Aldeyra Therapeutics is (3.87 - 4.13), which suggest Aldeyra Therapeutics is a Buy
- The Bollinger Bands (100) for Aldeyra Therapeutics is (3.11 - 4.05), which suggest Aldeyra Therapeutics is a Buy
* Aldeyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.